• Physicians
  • By Specialty
  • By Name
  • By Language
• Medical Services
• Primary Care Centers
  • Centerville Health Center
  • Greenwood Health Center (Midvale)
  • Madsen Health Center (SLC)
  • Parkway Health Center (Orem)
  • Redstone Health Center (Park City)
  • Redwood Health Center (South SLC)
  • South Jordan Health Center
  • Sugar House Health Center
  • Stansbury Health Center (Tooele)
  • Urgent Care / After Hours
  • Westridge Health Center (West Valley City)
• Hospitals & Specialty Centers
  • University Hospital & Clinics
  • Cardiovascular Center
  • Clinical Neurosciences Center
  • Huntsman Cancer Hospital
  • Moran Eye Center
  • Rehabilitation Center
  • University Neuropsychiatric Institute
  • University Orthopaedic Center
  • Utah Diabetes Center
  • Other Specialty Centers

Christopher M. Hull, M.D.

Assistant Professor of Dermatology

• B.A.: 1994 University of Colorado-Boulder
• M.D.: 2000 University of Washington School of Medicine
• Internship in Internal Medicine: 2000-2001 University of Utah
• Residency in Dermatology: 2001-2004, University of Utah
• Visiting Instructor in Dermatology 2004-2005, University of Utah
• Assistant Professor in Dermatology 2005-Current, University of Utah
• Adjunct Assistant Professor in Infectious Disease: 2004-Current, University of Utah
• Board Certification in Dermatology

Clinical and Research Interests

• Dr. Hull's clinical interests are blistering diseases, such as bullous pemphigoid, pemphigus vulgaris, and dermatitis herpetiformis; medical dermatology, including cutaneous lupus, dermatomyositis, vasculitis, lichen planus, and sarcoidosis; and general dermatology. His research interests include dermatitis herpetiformis, bullous pemphigoid, and herpes simplex virus. Dr. Hull is also a principal investigator for several clinical trials.

Selected Publications

• Jaskowski TD, Hamblin T, Wilson AR, Hill HR, Book LS, Meyer LJ, Zone JJ, Hull CM. IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease. J Invest Dermatol. 2009; (Epub ahead of print).
• Hull CM, Liddle M, Hansen N, Meyer LJ, Schmidt L, taylor T, Jaskowski TD, Hill HR, Zone JJ. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol. 2008; 159(1), 120-4.
• Donaldson, M, Zone J, Schmidt L, Taylor T, Neuhausen S, Hull C, Meyer L. (2007). Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis. Journal of Investigative Dermatology, 127(5), 1268-1270.
• Hull CM, Spruance SL. (2007). Situational Antiviral Drug Prophylaxis for Herpes Simplex Virus Type 1 Recurrences. Herpes, 14:1.
• Zone JJ, Taylor T, Hull C, Schmidt L, Meyer L. (2007). IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. Journal of Investigative Dermatology, The, 127(5), 1167-1174.
• Samolitis NJ, Hull CM, Leiferman KM, Zone JJ. (2006). Dermatitis herpetiformis and partial IgA deficiency. J Am Acad Dermatol, 54(5 Suppl), S206-9.
• Hull C, Spruance S, Tyring S, Kamal H. (2006). Single dose famciclovir for the treatment of herpes labialis. Current Medical Research and Opinion, 22(9):1699-702.
• Zone JJ, Hull CM. (2004). Warning: bread may be harmful to your health. J Am Acad Dermatol, 51(1 Suppl), S27-8.
• Hull C, Larson A, Leachman S. (2003). Pharmacogenetic candidate genes in melanoma. Pharmacogenomics, 4(6), 753-765.
• Hull C, Zone JJ. (In Press). Dermatitis herpetiformis and linear IgA bullous dermatosis. In Bolognia J, Jorizzo J, Rapini R (Eds.), Dermatology (2nd Edition). Elsevier Mosby.

Dr. Christopher Hull's Complete CV